Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles

Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles

Among various immunotherapies, natural killer (NK) cell cancer immunotherapy using adoptive transfer of NK cells takes a unique position by targeting tumor cells that evade the host immune surveillance. As the first-line innate effector cell, it has been revealed that NK cells have distinct mechanis...

Full description

Bibliographic Details
Main Authors: Kwang-Soo Kim, Dong-Hwan Kim, Dong-Hyun Kim
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Pharmaceutics
Subjects:
nanoparticles
NK cell therapy
cancer immunotherapy
tumor microenvironment
NK cell activation
Online Access:https://www.mdpi.com/1999-4923/13/4/525

Internet

https://www.mdpi.com/1999-4923/13/4/525

Similar Items